No. of items: 228
Sorting after results
14/08/2019
German medical biotechnology in the spotlight
Germany's medical biotechnology sector is one of the most dynamic in the world. A new video from Germany Trade and Invest (GTAI) and the Export Initiative for the German Healthcare Industry, HEALTH MADE IN GERMANY, provides insight and facts & figures on this innovative, growing field.
06/08/2019
Thriving German medtech ready for medical revolution
The association that represents Germany's medical technology companies, BVMed, is predicting that the medtech sector will continue growing. It cites experts forecasting an annual growth rate of four to five percent. This is according to the BVMed Annual Report 2018/19, which is based on a survey of …
31/07/2019
German medical biotechnology's record breaking trend
The German medical biotechnology industry is growing and surpassing its performance year after year. The Biotechnologie Jahrbuch 2018 (Biotechnology Yearbook 2018), published by biotechnologie.de and prepared by BIOCOM, says that last year, financing for innovation and research and development (R&D) …
23/07/2019
Innovation awards for promising biotechnology
The Council of German BioRegions (AK BioRegio) has presented the annual Innovation Prize of German BioRegions to some of the country's most promising concepts in biotech research. In 2019, the jury used an interactive format in reaching its decision for the first time in the 12-year history of the …
16/07/2019
Germany the place to be for innovative healthcare
Germany is proving to be an attractive location for groundbreaking innovation in a number of areas, including healthcare. In its latest issue called "Outsourcing 4.0," Markets Germany magazine presents a company called Innoplexus as an example of the opportunities Germany holds for developers of …
09/07/2019
German R&D investment levels right on target
Germany invested more than three percent of its gross domestic product (GDP) in research and development (R&D) in 2017. According to a report by the Stifterverband, German companies and the government together spent nearly EUR 100 billion on R&D in 2017, or 3.03 percent of GDP.
05/07/2019
German medical biotech makes world class showing at Bio International
Germany’s medical biotechnology industry presented its major league capabilities at Bio International in Philadelphia. More than 50 German companies, regional biotech organizations, and clusters of excellence were at the German pavilion from June 3 to June 6 for the world’s top convention for the …
25/06/2019
Healthcare industry helps Germany reach record levels of FDI in 2018
Foreign direct investment (FDI) in Germany hit a record high last year, with more companies from abroad investing and locating in the country than ever before. The Federal Republic's inward investment agency, Germany Trade & Invest (GTAI) reports that healthcare played a role in attracting 2062 …
14/06/2019
HEALTH MADE IN GERMANY informs at Africa Health 2019
HEALTH MADE IN GERMANY joined nineteen companies at the German pavilion at Africa Health 2019, which was held at the end of May in Johannesburg. In addition to supporting exhibitors, the Export Initiative for the German Healthcare Industry implemented its program tailored to meet the needs of …
13/06/2019
AI series (part IV): The race is on – using data to transform drug development
Artificial intelligence (AI) applied in conjunction with "big data" has the potential to make drug development more rapid. These new technologies will also lead to the production of sophisticated, personalized medicines. The pharmaceutical industry is already making efforts to speed advances in …
- Recommend this page:
- Print view